PHORM CORP ORD NPV (DI) (PHRM.L, LSE, LSE:PHRM)

PHRM Share PerformanceMore

52 week high14.90 03/03/14
52 week low8.00 18/02/14
52 week change -1.50 (-12.63%)
4 week volume6,938,975 21/11/14

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Equity Fundraising

RNS Number: 0571Z Phorm Corporation Limited 08 December 2014 NEITHER THIS ANNOUNCEMENT NOR ANY PART OF IT CONSTITUTES AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE OR ACQUIRE ANY NEW ORDINARY SHARES IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SO...

TR-1: Notification of major interest in shares

RNS Number: 4229V Phorm Corporation Limited 28 October 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Phorm Corporation Limited 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of votin...

Phorm's raising

Phorm Corporation has today raised a total of about 4.47m before expenses via a conditional placement of 5.91m new share...

Equity fundraising of ?4.47 million

RNS Number: 7103T Phorm Corporation Limited 08 October 2014 NEITHER THIS ANNOUNCEMENT NOR ANY PART OF IT CONSTITUTES AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE OR ACQUIRE ANY NEW ORDINARY SHARES IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOL...

Phorm Corp gives upbeat operational update

Phorm Corp said its technology has now been deployed to 16 internet service providers -- versus 10 earlier -- and that the nu...

Operational Update

RNS Number: 4734T Phorm Corporation Limited 06 October 2014 6 October 2014 Phorm Corporation Limited ("Phorm" or the "Company") Operational Update Phorm (AIM: PHRM), a leading internet personalisation technology company, announces an unaudited operational and financial update demonstrating continued robust growth in the group's revenues and k...

Phorm Corp marginally narrows H1 pretax loss

Phorm Corp booked an H1 pretax loss of $22.95m, from a marginally lower loss of $24.83m a year earlier. Revenue totalled...

Phorm Corp marginally narrows H1 pretax loss